B J Pomerants, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 7450 Hospital Dr, Ste 150, Dublin, OH 43016 Phone: 614-766-5050 Fax: 614-766-8080 |
Xiaoyi Teng, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 6700 University Blvd, Dublin, OH 43016 Phone: 614-293-8536 Fax: 614-293-8902 |
Dr. Kyongjune Benjamin Lee, M.D. Surgery - Vascular Surgery Medicare: Medicare Enrolled Practice Location: 6700 University Blvd Fl 5, Dublin, OH 43016 Phone: 614-293-8536 Fax: 614-293-8902 |
Dr. Jason Daniel Shoemaker, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 7450 Hospital Dr Ste 150, Dublin, OH 43016 Phone: 614-766-5050 Fax: 740-766-8080 |
Ernest Debourbon, MD Surgery Medicare: Medicare Enrolled Practice Location: 5060 Bradenton Ave, Suite B, Dublin, OH 43017 Phone: 614-793-8346 Fax: 614-793-8349 |
Dr. Stephen M Glatz, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 7450 Hospital Dr, Ste 150, Dublin, OH 43016 Phone: 614-766-5050 Fax: 614-766-8080 |
Gregory S Vereb, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 7450 Hospital Dr Ste 150, Dublin, OH 43016 Phone: 614-766-5050 Fax: 614-766-8080 |
Gabriel Krenitsky, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 425 Metro Pl N, Suite 175, Dublin, OH 43017 Phone: 614-937-4883 |
Dr. Steven Roger Wanamaker, MD Surgery Medicare: Medicare Enrolled Practice Location: 6103 Karrer Pl, Dublin, OH 43017 Phone: 614-566-8805 |
News Archive
VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.
Enzo Biochem, Inc. (NYSE:ENZ) announced today that Kevin Krenitsky, MD, President of Enzo Clinical Labs, will present at the 27th Annual Lab Institute '09, sponsored by Washington G2 Reports, on September 23, 2009 in Arlington, Virginia.
November is Chronic Obstructive Pulmonary Disease (COPD) Awareness Month. COPD, also known as emphysema, is the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals.
A new 'fertility chip', developed by researchers at the University of Twente's MESA+ Institute for Nanotechnology, can accurately count spermatozoa in sperm. This is an important step towards the development of a compact device for reliable 'pre-scanning' of male fertility. The researchers are publishing the invention of the chip in the scientific journal Lab on a Chip.
Understanding the cellular response to DNA strand breaks is crucial to decipher the mechanisms maintaining the integrity of our genome. In eukaryotic cells, the molecular events triggered by DNA damage are strongly influenced by the local chromatin environment surrounding the lesion. The ensuing DNA repair process, in turn, impacts on chromatin structure. In order to understand how these two fundamental processes are mutually connected, both chromatin rearrangements induced by DNA damage as well as DNA repair activity have to be visualized in living cells.
› Verified 7 days ago